Unresectable Malignant Neoplasm

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

Association of Radiochemotherapy and Immunotherapy for the Treatment of Unresectable Oesophageal caNcer

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)

Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors

QUILT-3.091 NANT Chordoma Vaccine vs Radiation in Subjects With Unresectable Chordoma.

Chemoradiotherapy in Unresectable Esophageal Cancer

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer

ImmunoPET With an Anti-CD8 Imaging Agent

Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Treat Patients With Advanced Cancer

Muscadine Grape Skin Extract in Treating Patients With Malignancy That Is Metastatic or Cannot Be Removed by Surgery

Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors

Neoadjuvant Pembrolizumab for Unresectable Stage III and Unresectable Stage IV Melanoma

Ilorasertib in Treating Patients With CDKN2A-deficient Advanced or Metastatic Solid Cancers That Cannot Be Removed by Surgery

Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by Surgery

Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain

Bevacizumab in Combination With Chemotherapy in Patients With Advanced or Recurrent Non-squamous NSCLC